SAS^® Drug Development

In the Spotlight Managed Innovation, Assured Compliance Learn how to assemble data to foster better collaboration, get up-to-date information during clinical trials and make informed decisions earlier in the trial process.

Benefits A single version of the truth. SAS Drug Development delivers full data integration and standardization via a centralized information repository that gives researchers throughout the organization direct access to both the research content and embedded intelligence tools at all stages of the clinical R&D process. Full compliance with industry standards. SAS Drug Development provides the ability to meet industry expectations for managing research information content in accordance with government regulations, including 21 CFR Part 11, good industry practices (GxP) and sound business practices. Automated integrity, traceability and transparency. The degree of transparency and traceability of all data analysis activities provided by the solution ensures ongoing quality control and quality assurance, and makes it easy to confidently address inquiries from regulatory agencies. More confidence in research decisions. Researchers can easily review multiple data sources to analyze research across trials, phases and therapeutic areas. This comprehensive view makes it easier to make go/no-go research program decisions earlier in the process. Shorter development cycles. With the ability to make more confident decisions and analyze data from a single repository, researchers can reduce the time spent searching for, gathering and aggregating data for analysis. The solution also helps streamline and automate research and analysis tasks. Download the complete SAS Drug Development Fact Sheet.(PDF)

How SAS^® Is Different

• A standardized, centralized repository. SAS Drug Development integrates data from all relevant sources, stores all information related to a clinical research program, and brings this information together in a standardized, centralized repository.
• Streamlined processes. By providing immediate access and ongoing insight into project progress, SAS Drug Development gives organizations better control over the deployment of resources, as well as the streamlining of clinical R&D processes and tasks.
• Integrated SAS^® program development and execution. An embedded program development environment provides the ability to easily develop SAS programs and macro libraries, review log files and test program functionality.
• A truly collaborative environment. Research scientists and less technical users have direct access to research data, statistical results and all other relevant clinical research content via a secure, user-friendly interface.
• Full compliance. SAS Drug Development was carefully designed to meet existing and emerging government regulations, including 21 CFR Part 11, as well as good industry practices and sound business methodologies.